Article
Mutational signatures are markers of drug sensitivity of cancer cells.
Nature communications - 25 May 2022
Levatić Jurica, Salvadores Marina, Fuster-Tormo Francisco, Supek Fran
Abstract excerpt
Genomic analyses have revealed mutational footprints associated with DNA maintenance gone awry, or with mutagen exposures. Because cancer therapeutics often target DNA synthesis or repair, we asked if mutational signatures make useful markers of drug sensitivity. We detect mutational signatures in cancer cell line exomes (where matched healthy tissues are not available) by adjusting for the confounding germline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
